| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...857381J |
| P356 | DOI | 10.1371/JOURNAL.PONE.0057381 |
| P932 | PMC publication ID | 3590217 |
| P698 | PubMed publication ID | 23483908 |
| P5875 | ResearchGate publication ID | 236040209 |
| P2093 | author name string | Tim Lu | |
| Dirk van den Boom | |||
| Mathias Ehrich | |||
| Paul Oeth | |||
| Amin R Mazloom | |||
| Cosmin Deciu | |||
| Glenn E Palomaki | |||
| Graham McLennan | |||
| Jacob A Canick | |||
| John Tynan | |||
| Roger C Tim | |||
| Sung K Kim | |||
| Taylor J Jensen | |||
| Tricia Zwiefelhofer | |||
| Željko Džakula | |||
| Zhanyang Zhu | |||
| P2860 | cites work | A new non-invasive prenatal diagnosis of Down syndrome through epigenetic markers and real-time qPCR. | Q51346655 |
| Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. | Q51349861 | ||
| Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. | Q53063252 | ||
| Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus | Q56937251 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Non-invasive prenatal diagnosis of fetal aneuploidies using massively parallel sequencing-by-ligation and evidence that cell-free fetal DNA in the maternal plasma originates from cytotrophoblastic cells | Q57079533 | ||
| Chromosome-selective sequencing of maternal plasma cell–free DNA for first-trimester detection of trisomy 21 and trisomy 18 | Q61847821 | ||
| Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting | Q83395075 | ||
| Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood | Q24657306 | ||
| Fast gapped-read alignment with Bowtie 2 | Q27860699 | ||
| Free R value: a novel statistical quantity for assessing the accuracy of crystal structures | Q27860894 | ||
| Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing | Q28742844 | ||
| DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study | Q30414408 | ||
| Quantification of Fetal DNA by Use of Methylation-Based DNA Discrimination | Q30987480 | ||
| Personalized copy number and segmental duplication maps using next-generation sequencing. | Q33498358 | ||
| DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study | Q34029044 | ||
| Fast computation and applications of genome mappability | Q34140534 | ||
| Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. | Q34168875 | ||
| Differential DNA methylation as a tool for noninvasive prenatal diagnosis (NIPD) of X chromosome aneuploidies | Q34239768 | ||
| Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
| Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study | Q34482155 | ||
| Noninvasive prenatal diagnosis of a fetal microdeletion syndrome | Q35020502 | ||
| Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy | Q36406163 | ||
| Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma | Q37010246 | ||
| Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. | Q40028555 | ||
| Detection of microdeletion 22q11.2 in a fetus by next-generation sequencing of maternal plasma | Q44554684 | ||
| DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations | Q47764889 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e57381 | |
| P577 | publication date | 2013-03-06 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | High-throughput massively parallel sequencing for fetal aneuploidy detection from maternal plasma | |
| P478 | volume | 8 |
| Q92498648 | A new era in aneuploidy screening: cfDNA testing in >30,000 multifetal gestations: Experience at one clinical laboratory |
| Q35552815 | Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis |
| Q36173927 | Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis |
| Q31011773 | Application of risk score analysis to low-coverage whole genome sequencing data for the noninvasive detection of trisomy 21, trisomy 18, and trisomy 13. |
| Q37734063 | Attitude of Reproductive Healthcare Providers to Prenatal Diagnosis in a Low Resource Nigerian Setting. |
| Q59795751 | Autoimmune disorders but not heparin are associated with cell-free fetal DNA test failure |
| Q46934240 | Cell-free fetal DNA in maternal circulation after chorionic villous sampling |
| Q87919240 | Cell-free fetal DNA versus maternal serum screening for trisomy 21 in pregnant women with and without assisted reproduction technology: a prospective interventional study |
| Q37279297 | Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing |
| Q44594608 | Comment on "Clinical application of massively parallel sequencing-based prenatal non-invasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors". |
| Q36454528 | Detection of complex deletions in chromosomes 13 and 21 in a fetus by noninvasive prenatal testing |
| Q51025463 | Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts. |
| Q37722183 | Diagnosis for choroideremia in a large Chinese pedigree by next‑generation sequencing (NGS) and non‑invasive prenatal testing (NIPT). |
| Q45246040 | Evaluation of the impact of density gradient centrifugation on fetal cell loss during enrichment from maternal peripheral blood |
| Q38860845 | Expanding non-invasive prenatal testing beyond chromosomes 21, 18, 13, X and Y. |
| Q91695814 | Factors affecting cell-free DNA fetal fraction: statistical analysis of 13,661 maternal plasmas for non-invasive prenatal screening |
| Q39375461 | Genome-wide cfDNA screening: clinical laboratory experience with the first 10,000 cases |
| Q47618331 | Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women. |
| Q35665317 | High-resolution characterization of sequence signatures due to non-random cleavage of cell-free DNA. |
| Q35667159 | Impact of Cell-Free Fetal DNA Screening on Patients' Choice of Invasive Procedures after a Positive California Prenatal Screen Result |
| Q37412801 | Implementation of non-invasive prenatal testing by semiconductor sequencing in a genetic laboratory |
| Q38262952 | Implementation of whole genome massively parallel sequencing for noninvasive prenatal testing in laboratories |
| Q36293841 | Improving the Positive Predictive Value of Non-Invasive Prenatal Screening (NIPS) |
| Q37529449 | Investigating and correcting plasma DNA sequencing coverage bias to enhance aneuploidy discovery |
| Q90474937 | Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration |
| Q43524466 | Maternal plasma DNA testing for aneuploidy in pregnancies achieved by assisted reproductive technologies |
| Q36335133 | Non-Invasive Screening Tools for Down's Syndrome: A Review |
| Q34301776 | Non-invasive prenatal chromosomal aneuploidy testing--clinical experience: 100,000 clinical samples |
| Q36895493 | Non-invasive prenatal diagnosis of Duchenne and Becker muscular dystrophies by relative haplotype dosage |
| Q37745036 | Non-invasive prenatal diagnosis of spinal muscular atrophy by relative haplotype dosage |
| Q46170290 | Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma |
| Q38895114 | Noninvasive prenatal screening at low fetal fraction: comparing whole-genome sequencing and single-nucleotide polymorphism methods. |
| Q37043652 | Prenatal diagnosis of common fetal aneuploidies: Scenario in India |
| Q48180522 | Response to "Noninvasive prenatal screening at low fetal fraction: comparing whole-genome sequencing and single-nucleotide polymorphism methods". |
| Q38661271 | Systematic review and meta-analysis of non-invasive prenatal DNA testing for trisomy 21: implications for implementation in China |
| Q52659515 | Using massively parallel shotgun sequencing of maternal plasmatic cell-free DNA for cytomegalovirus DNA detection during pregnancy: a proof of concept study. |
| Q35595108 | Whole genome bisulfite sequencing of cell-free DNA and its cellular contributors uncovers placenta hypomethylated domains |
Search more.